跳至主要内容
临床试验/NCT04595058
NCT04595058已完成不适用

Multicenter, Randomized and Comparative Study of Lumen-apposing Metal Stents With or Without Coaxial Plastic Stent for Endoscopic Ultrasound-guided Transmural Biliary Drainage

Hospital Universitari de Bellvitge2 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2020年11月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
123
试验地点
2
主要终点
Recurrent biliary obstruction (RBO)

研究概览

简要总结

The aim of the study is to evaluate technical, clinical and safety outcomes of lumen-apposing metal stent (LAMS) with and without a coaxial double-pigtail plastic stent (DPS) in EUS-guided choledochoduodenostomies (CDS) for the management of biliary obstruction.

详细描述

The introduction of specific biliary lumen-apposing metal stents (LAMS) represented a great technical improvement in EUS-guided transmural Biliary drainage (BD) of distal malignant biliary obstruction Data is still limited, but recent studies and reviews have been reported with acceptable technical and clinical success. However, some concerns exist regarding its safety, as secondary adverse events

There are doubts concerning the possible benefits derived from the insertion of double-pigtail plastic stents (DPS) within the lumen-apposing metal stents (LAMS) in the EUS-guided choledochoduodenostomy (CDS). Our hypothesis is that adding a coaxial plastic stent may offer benefits in terms of safety in CDS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Distal biliary strictures,
  • A prior failed attempt at biliary drainage
  • informed consent provided by the patient.

排除标准

  • were as follows:
  • younger than age 18 years,
  • coagulopathy (international normalized ratio >1.5, marked thrombocytopenia with a platelet count <50,000/mL, or patient on anticoagulation therapy),
  • critical illness.

结局指标

主要结局

Recurrent biliary obstruction (RBO)

时间窗: 12 months

Recurrent biliary obstruction (RBO) has been defined as a composite endpoint of either occlusion or migration.

Safety (Adverse events)

时间窗: 12 months

Safety will be measured by careful and comparative evaluation of adverse effects in both groups.

次要结局

  • Survival(12 months)
  • Clinical success(2 weeks)
  • Technical success(24 hours.)

研究者

发起方
Hospital Universitari de Bellvitge
申办方类型
Other
责任方
Principal Investigator
主要研究者

Joan B Gornals

Head of Interventional Digestive Endoscopy Unit.

Hospital Universitari de Bellvitge

研究点 (2)

Loading locations...

相似试验